BSE filing, NSE: DIVISLAB. Summary written from the filing by ALFA Finder's alert engine.
Divi's Laboratories Ltd: key numbers
- Share price
- ₹9,933.50
- Market cap
- ₹2,63,703 Cr
- Revenue (annual)
- ₹10,560 Cr
- Net profit (annual)
- ₹2,568 Cr
- P/E (TTM)
- 90.2×Sector 47.2×
- Promoter holding
- 51.88%+0.00% QoQ
- FII holding
- 20.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Divi's Laboratories Ltd
All →Divi's Laboratories Board Meeting Date
Divi's Laboratories will hold a board meeting on November 07, 2026, to approve unaudited standalone and consolidated financial results for the quarter ended September 30, 2026.
Divi's Laboratories Other Announcement
Divis Laboratories Ltd has submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Regulation 31.
Divi's Laboratories Other Announcement
Immediate relatives of the company purchased 462 shares for a total consideration of Rs. 0.43 Crore in the open market.
- Value
- ₹0.43 Cr
Divi's Laboratories Other Announcement
Divis Laboratories Ltd reported a share pledge by Designated Person Nimmagadda Venkata Anirudh involving securities valued at ₹3.33 Crore. Additionally, Joshita Divi acquired shares worth ₹0.96 Crore via market purchase.
- Value
- ₹4.29 Cr
Divi's Laboratories Other Announcement
An immediate relative of a Divis Laboratories promoter bought equity shares worth ₹0.58 Crore through a market purchase.
- Value
- ₹0.58 Cr
Divi's Laboratories Other Announcement
Designated Person PRASAD Y.T.S. disclosed the release of two share pledges involving 2,734 equity shares. The combined transaction value of the released pledges is Rs. 2.56 Crore.
- Value
- ₹2.56 Cr
Other board meeting date announcements
All →Gini Silk Mills Board Meeting Date
Gini Silk Mills Ltd intimated BSE that its Board will meet on 06 Nov 2026 to consider unaudited Q2/H1 FY27 results. No financial figures are disclosed in this advance notice.
Challani Capital Board Meeting Date
Challani Capital intimated that its Board will meet on 11 Nov 2026. It proposes to approve Q1 results and noted the trading window closure.
Mirza International Board Meeting Date
Mirza International rescheduled its board meeting from November 3 to November 13, 2026, to approve financial results. The trading window stays closed till results declaration.
Biofil Chemicals & Pharmaceuticals Board Meeting Date
Biofil Chemicals intimates that its Board will meet on 14 Nov 2026 to approve unaudited Q1/H1 FY27 results. No financial figures or other material outcomes are disclosed yet.
T T Board Meeting Date
T T Ltd intimated its board will meet on 16 November 2026 to consider a share buyback. Trading window closed from 3 November 2026.
KCL Infra Projects Board Meeting Date
KCL Infra Projects scheduled its Q2 FY27 board meeting for 14 Nov 2026 to approve unaudited standalone results. No transaction or monetary figure is disclosed in this advance intimation.